RAPT Therapeutics, Inc. (RAPT) Change in Accured Expenses (2020 - 2024)
RAPT Therapeutics (RAPT) has disclosed Change in Accured Expenses for 5 consecutive years, with $3.1 million as the latest value for Q4 2024.
- Quarterly Change in Accured Expenses rose 4452.11% to $3.1 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was -$8.5 million through Dec 2024, down 215.32% year-over-year, with the annual reading at -$8.5 million for FY2024, 215.32% down from the prior year.
- Change in Accured Expenses hit $3.1 million in Q4 2024 for RAPT Therapeutics, up from -$4.4 million in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $7.3 million in Q1 2023 to a low of -$6.4 million in Q2 2024.
- Historically, Change in Accured Expenses has averaged $295450.0 across 5 years, with a median of $235500.0 in 2021.
- Biggest five-year swings in Change in Accured Expenses: tumbled 543.51% in 2023 and later surged 4452.11% in 2024.
- Year by year, Change in Accured Expenses stood at -$2.8 million in 2020, then grew by 7.06% to -$2.6 million in 2021, then soared by 89.95% to -$263000.0 in 2022, then soared by 73.0% to -$71000.0 in 2023, then soared by 4452.11% to $3.1 million in 2024.
- Business Quant data shows Change in Accured Expenses for RAPT at $3.1 million in Q4 2024, -$4.4 million in Q3 2024, and -$6.4 million in Q2 2024.